{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:13:24Z","timestamp":1778800404258,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.micinf.2024.105372","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T07:38:33Z","timestamp":1717573113000},"page":"105372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Magdy","family":"El-Salhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0436-0383","authenticated-orcid":false,"given":"Odd Helge","family":"Gilja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Gunnar","family":"Hatlebakk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.micinf.2024.105372_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.micinf.2024.105372_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","article-title":"The super-donor phenomenon in fecal microbiota transplantation","volume":"9","author":"Wilson","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"7698","key":"10.1016\/j.micinf.2024.105372_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2024.105372_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17474124.2018.1447380","article-title":"Fecal microbiota transplantation for managing irritable bowel syndrome","volume":"12","author":"El-Salhy","year":"2018","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.micinf.2024.105372_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/apt.13236","article-title":"Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD","volume":"42","author":"Cas\u00e9n","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.micinf.2024.105372_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000488773","article-title":"Dysbiosis in functional bowel disorders","volume":"72","author":"Enck","year":"2018","journal-title":"Ann Nutr Metab"},{"issue":"8","key":"10.1016\/j.micinf.2024.105372_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081824","article-title":"Diet in irritable bowel syndrome (IBS): interaction with gut microbiota and gut hormones","volume":"11","author":"El-Salhy","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.micinf.2024.105372_bib8","article-title":"Current status of fecal microbiota transplantation for irritable bowel syndrome","author":"El-Salhy","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.micinf.2024.105372_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ebiom.2019.02.023","article-title":"Bacterial viability in faecal transplants: which bacteria survive?","volume":"41","author":"Papanicolas","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.micinf.2024.105372_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","article-title":"Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial","volume":"160","author":"Holvoet","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.micinf.2024.105372_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.micinf.2024.105372_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.micinf.2024.105372_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/apt.15740","article-title":"Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome","volume":"51","author":"Lahtinen","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.micinf.2024.105372_bib14","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","article-title":"Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study","volume":"67","author":"Halkj\u00e6r","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.micinf.2024.105372_bib15","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000034","article-title":"The effect of allogenic versus autologous fecal microbiota transfer on symptoms, visceral perception and fecal and mucosal microbiota in irritable bowel syndrome: a randomized controlled study","volume":"10","author":"Holster","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"20","key":"10.1016\/j.micinf.2024.105372_bib16","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3748\/wjg.v29.i20.3185","article-title":"Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"29","author":"Halkj\u00e6r","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.micinf.2024.105372_bib17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2022.06.020","article-title":"Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at 3 Years after transplantation","volume":"163","author":"El-Salhy","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2024.105372_bib18","article-title":"Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome","author":"El-Salhy","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.micinf.2024.105372_bib19","article-title":"Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome","author":"El-Salhy","year":"2023","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.micinf.2024.105372_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.micinf.2024.105372_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.micinf.2024.105372_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-230X-8-30","article-title":"Evaluation of the Birmingham IBS symptom questionnaire","volume":"8","author":"Roalfe","year":"2008","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.micinf.2024.105372_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MCP.0000000000000496","article-title":"The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases","volume":"24","author":"Hendriks","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.micinf.2024.105372_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","article-title":"Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire","volume":"95","author":"Drossman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.micinf.2024.105372_bib25","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","article-title":"AGA technical review on irritable bowel syndrome","volume":"123","author":"Drossman","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.micinf.2024.105372_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MEG.0000000000002519","article-title":"A\u00a0systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome","volume":"35","author":"Rokkas","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"18","key":"10.1016\/j.micinf.2024.105372_bib27","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3748\/wjg.v27.i18.2219","article-title":"Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome","volume":"27","author":"El-Salhy","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.micinf.2024.105372_bib28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/00365521.2022.2064725","article-title":"The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms","volume":"57","author":"El-Salhy","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.micinf.2024.105372_bib29","article-title":"Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation","author":"El-Salhy","year":"2022","journal-title":"Neuro Gastroenterol Motil"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:04:24Z","timestamp":1778799864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457924001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1286457924001084"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105372","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}],"article-number":"105372"}}